Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study

<p>Abstract</p> <p>Background</p> <p>Overall therapeutic outcomes of advanced non-small-cell lung cancer (NSCLC) are poor. The dendritic cell (DC) immunotherapy has been developed as a new strategy for the treatment of lung cancer. The purpose of this study was to evalu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vassallo José, Gilli Simone CO, Almeida Maria T, Barbeiro Aristóteles S, Honma Helen N, Perroud Maurício W, Saad Sara TO, Zambon Lair
Format: Artigo
Jezik:Inglês
Izdano: BMC 2011-06-01
Serija:Journal of Experimental & Clinical Cancer Research
Online pristup:http://www.jeccr.com/content/30/1/65
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items